Why did BMS buy Mirati?
Could you elaborate on the reasoning behind BMS's decision to acquire Mirati? What strategic benefits does this acquisition offer to BMS, and how does it align with their long-term goals and vision in the healthcare industry? Additionally, what specific factors or market trends influenced their decision to invest in Mirati's technology or pipeline of drugs? Furthermore, how does this acquisition position BMS in the competitive landscape, and what impact could it have on their financial performance and shareholder value in the coming years?
Who owns BMS?
Could you please clarify who exactly owns BMS? Is it a publicly traded company, a private entity, or perhaps a consortium of investors? Are there any major shareholders or stakeholders that have a significant influence on the company's operations and decision-making processes? Additionally, is there any information available regarding the ownership structure and the history of BMS's ownership? Understanding the ownership of BMS is crucial in assessing its credibility, stability, and potential for growth in the cryptocurrency and finance industry.